Pellagra encephalopathy as a differential diagnosis for Creutzfeldt-Jakob disease

Metab Brain Dis. 2012 Jun;27(2):231-5. doi: 10.1007/s11011-012-9308-8. Epub 2012 Apr 27.

Abstract

In the present study we evaluated cases referred as suspected Creutzfeldt-Jakob disease (CJD). Five out of 59 without prion disease showed neuropathological features of pellagra encephalopathy with widespread chromatolytic neurons (age range 40-48 years at death; one woman). These patients presented with a progressive neuropsychiatric disorder lasting for 2 to 24 months. Common symptoms included gait disorder, para- or tetraspasticity, extrapyramidal symptoms, incontinence, and myoclonus. Protein 14-3-3 in the cerebrospinal fluid was examined in a single patient and was positive, allowing the clinical classification as probable sporadic CJD. Pellagra encephalopathy may be considered as a differential diagnosis of CJD including detection of protein 14-3-3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 14-3-3 Proteins / cerebrospinal fluid
  • Adult
  • Aged
  • Aged, 80 and over
  • Brain / pathology
  • Creutzfeldt-Jakob Syndrome / diagnosis*
  • Creutzfeldt-Jakob Syndrome / pathology
  • Creutzfeldt-Jakob Syndrome / psychology
  • Dementia / etiology
  • Dementia / psychology
  • Diagnosis, Differential
  • Disease Progression
  • Electroencephalography
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Pellagra / diagnosis*
  • Pellagra / pathology
  • Pellagra / psychology
  • Retrospective Studies

Substances

  • 14-3-3 Proteins